{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:56:24Z","timestamp":1792796184573,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK130225"],"award-info":[{"award-number":["R01DK130225"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74641-5","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:06:13Z","timestamp":1782234373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autoantigen-loaded Polymeric Microparticles associate with B cells and promote tolerogenic antigen presentation in a mouse model of experimental autoimmune encephalomyelitis"],"prefix":"10.1038","volume":"17","author":[{"given":"Nicole Rose","family":"Lukesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Barbery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3502-977X","authenticated-orcid":false,"given":"Kierstin A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ontiveros-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4078-5362","authenticated-orcid":false,"given":"Stephen A.","family":"Ehrenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan N.","family":"Woodring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"Mendell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denzel D.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Jahirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan A.","family":"Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0983-483X","authenticated-orcid":false,"given":"Sean R.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-5706","authenticated-orcid":false,"given":"Elizabeth G.","family":"Graham-Gurysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2533-5804","authenticated-orcid":false,"given":"Connor T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4711-1130","authenticated-orcid":false,"given":"Grace L.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8498-1496","authenticated-orcid":false,"given":"Sophia A.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Shilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca T.","family":"Stiepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaney","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Savoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Dotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4458-9091","authenticated-orcid":false,"given":"Yuliya","family":"Pylayeva-Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland M.","family":"Tisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Bachelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1820-8382","authenticated-orcid":false,"given":"Kristy M.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"74641_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944\u2013950 (2002).","journal-title":"Nat. Immunol."},{"key":"74641_CR2","doi-asserted-by":"publisher","unstructured":"Lassmann, H. et al. Multiple sclerosis pathology. Cold Spring Harb Perspect Med. 8, https:\/\/doi.org\/10.1101\/cshperspect.a028936 (2018).","DOI":"10.1101\/cshperspect.a028936"},{"key":"74641_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan, S. S. & Lieberman, P. M. Epstein-Barr virus and multiple sclerosis. Nat. Rev. Microbiol 21, 51\u201364 (2023).","journal-title":"Nat. Rev. Microbiol"},{"key":"74641_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/08916934.2012.665527","volume":"45","author":"E Marino","year":"2012","unstructured":"Marino, E. & Grey, S. T. B cells as effectors and regulators of autoimmunity. Autoimmunity 45, 377\u2013387 (2012).","journal-title":"Autoimmunity"},{"key":"74641_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fimmu.2014.00092","volume":"5","author":"AM Avalos","year":"2014","unstructured":"Avalos, A. M. & Ploegh, H. L. Early BCR events and antigen capture, processing, and loading on MHC class II on B Cells. Front Immunol. 5, 92 (2014).","journal-title":"Front Immunol."},{"key":"74641_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/314537a0","volume":"314","author":"A Lanzavecchia","year":"1985","unstructured":"Lanzavecchia, A. et al. Antigen-specific interaction between T and B cells. Nature 314, 537\u2013539 (1985).","journal-title":"Nature"},{"key":"74641_CR7","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser, S. L. & Cree, B. A. C. Treatment of multiple sclerosis: a review. Am. J. Med. 133, 1380\u20131390 e1382 (2020).","journal-title":"Am. J. Med"},{"key":"74641_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","volume":"20","author":"DSW Lee","year":"2021","unstructured":"Lee, D. S. W., Rojas, O. L. & Gommerman, J. L. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat. Rev. Drug Discov. 20, 179\u2013199 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74641_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1126\/science.2814489","volume":"246","author":"MD Howell","year":"1989","unstructured":"Howell, M. D. et al. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246, 668\u2013670 (1989).","journal-title":"Science"},{"key":"74641_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.0105-2896.2005.00247.x","volume":"204","author":"S Paust","year":"2005","unstructured":"Paust, S. & Cantor, H. Regulatory T cells and autoimmune disease. Immunol. Rev. 204, 195\u2013207 (2005).","journal-title":"Immunol. Rev."},{"key":"74641_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"74641_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41587-019-0015-4","volume":"37","author":"P Serra","year":"2019","unstructured":"Serra, P. & Santamaria, P. Antigen-specific therapeutic approaches for autoimmunity. Nat. Biotechnol. 37, 238\u2013251 (2019).","journal-title":"Nat. Biotechnol."},{"key":"74641_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1084\/jem.20182287","volume":"216","author":"JM Carballido","year":"2019","unstructured":"Carballido, J. M. & Santamaria, P. Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance. J. Exp. Med. 216, 247\u2013250 (2019).","journal-title":"J. Exp. Med"},{"key":"74641_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","volume":"42","author":"O Morante-Palacios","year":"2021","unstructured":"Morante-Palacios, O., Fondelli, F., Ballestar, E. & Martinez-Caceres, E. M. Tolerogenic dendritic cells in autoimmunity and inflammatory diseases. Trends Immunol. 42, 59\u201375 (2021).","journal-title":"Trends Immunol."},{"key":"74641_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104236","volume":"358","author":"I Janssens","year":"2020","unstructured":"Janssens, I. & Cools, N. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity? Cell Immunol. 358, 104236 (2020).","journal-title":"Cell Immunol."},{"key":"74641_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122500","volume":"631","author":"N Lukesh","year":"2023","unstructured":"Lukesh, N., Middleton, D. D., Bachelder, E. M. & Ainslie, K. M. Particle-Based therapies for antigen specific treatment of type 1 diabetes. Int J. Pharm. 631, 122500 (2023).","journal-title":"Int J. Pharm."},{"key":"74641_CR17","doi-asserted-by":"publisher","first-page":"15745","DOI":"10.1073\/pnas.1105200108","volume":"108","author":"CM Jewell","year":"2011","unstructured":"Jewell, C. M., Lopez, S. C. & Irvine, D. J. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc. Natl. Acad. Sci. USA 108, 15745\u201315750 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74641_CR18","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jaci.2017.08.049","volume":"142","author":"L Shen","year":"2018","unstructured":"Shen, L. et al. Protein corona-mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses. J. Allergy Clin. Immunol. 142, 1558\u20131570 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"74641_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nnano.2016.269","volume":"12","author":"F Chen","year":"2017","unstructured":"Chen, F. et al. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nat. Nanotechnol. 12, 387\u2013393 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"74641_CR20","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1021\/ja803947s","volume":"130","author":"EM Bachelder","year":"2008","unstructured":"Bachelder, E. M., Beaudette, T. T., Broaders, K. E., Dashe, J. & Frechet, J. M. Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. J. Am. Chem. Soc. 130, 10494\u201310495 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"74641_CR21","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1021\/acs.chemrev.6b00532","volume":"117","author":"EM Bachelder","year":"2017","unstructured":"Bachelder, E. M., Pino, E. N. & Ainslie, K. M. Acetalated dextran: a tunable and acid-labile biopolymer with facile synthesis and a range of applications. Chem. Rev. 117, 1915\u20131926 (2017).","journal-title":"Chem. Rev."},{"key":"74641_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jconrel.2018.01.027","volume":"273","author":"N Chen","year":"2018","unstructured":"Chen, N. et al. Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses. J. Control Release 273, 147\u2013159 (2018).","journal-title":"J. Control Release"},{"key":"74641_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0927-7765(02)00042-5","volume":"27","author":"K Makino","year":"2003","unstructured":"Makino, K. et al. Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres. Colloids Surf. B: Biointerfaces 27, 33\u201339 (2003).","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"74641_CR24","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/eji.200737984","volume":"38","author":"V Manolova","year":"2008","unstructured":"Manolova, V. et al. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404\u20131413 (2008).","journal-title":"Eur. J. Immunol."},{"key":"74641_CR25","doi-asserted-by":"publisher","first-page":"e60989","DOI":"10.1371\/journal.pone.0060989","volume":"8","author":"P Pacheco","year":"2013","unstructured":"Pacheco, P., White, D. & Sulchek, T. Effects of microparticle size and Fc density on macrophage phagocytosis. PLoS One 8, e60989 (2013).","journal-title":"PLoS One"},{"key":"74641_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.607945","volume":"11","author":"MV Baranov","year":"2020","unstructured":"Baranov, M. V., Kumar, M., Sacanna, S., Thutupalli, S. & van den Bogaart, G. Modulation of Immune Responses by Particle Size and Shape. Front Immunol. 11, 607945 (2020).","journal-title":"Front Immunol."},{"key":"74641_CR27","doi-asserted-by":"publisher","unstructured":"Stephen A. Ehrenzeller et al. Comparison of emulsion and spray methods for fabrication of rapamycin-loaded acetalated dextran microparticles. RSC Pharm. https:\/\/doi.org\/10.1039\/D4PM00054D (2024).","DOI":"10.1039\/D4PM00054D"},{"key":"74641_CR28","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1021\/acsnano.4c14698","volume":"19","author":"RT Stiepel","year":"2025","unstructured":"Stiepel, R. T. et al. Induction of antigen-specific tolerance in a multiple sclerosis model without broad immunosuppression. ACS Nano 19, 3764\u20133780 (2025).","journal-title":"ACS Nano"},{"key":"74641_CR29","doi-asserted-by":"publisher","first-page":"38950","DOI":"10.1021\/acsami.0c10276","volume":"12","author":"KM Moore","year":"2020","unstructured":"Moore, K. M. et al. Injectable, ribbon-like microconfetti biopolymer platform for vaccine applications. ACS Appl Mater. Interfaces 12, 38950\u201338961 (2020).","journal-title":"ACS Appl Mater. Interfaces"},{"key":"74641_CR30","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1021\/acs.molpharmaceut.8b00802","volume":"15","author":"MM Johnson","year":"2018","unstructured":"Johnson, M. M. et al. In vivo and cellular trafficking of acetalated dextran microparticles for delivery of a host-directed therapy for salmonella enterica serovar typhi infection. Mol. Pharm. 15, 5336\u20135348 (2018).","journal-title":"Mol. Pharm."},{"key":"74641_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jaut.2014.01.032","volume":"50","author":"S Sattler","year":"2014","unstructured":"Sattler, S. et al. IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut. J. Autoimmun. 50, 107\u2013122 (2014).","journal-title":"J. Autoimmun."},{"key":"74641_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02683-x","volume":"9","author":"X Meng","year":"2018","unstructured":"Meng, X. et al. Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease. Nat. Commun. 9, 251 (2018).","journal-title":"Nat. Commun."},{"key":"74641_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"R-X Wang","year":"2014","unstructured":"Wang, R.-X. et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 20, 633\u2013641 (2014).","journal-title":"Nat. Med."},{"key":"74641_CR34","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.4049\/jimmunol.0902473","volume":"183","author":"JB Foote","year":"2009","unstructured":"Foote, J. B. & Kearney, J. F. Generation of B cell memory to the bacterial polysaccharide \u03b1-1,3 dextran1.  J. Immunol. 183, 6359\u20136368 (2009).","journal-title":"J. Immunol."},{"key":"74641_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-3-030-12298-0_3","volume":"1073","author":"M Pietrowska","year":"2019","unstructured":"Pietrowska, M., Wlosowicz, A., Gawin, M. & Widlak, P. MS-based proteomic analysis of serum and plasma: problem of high abundant components and lights and shadows of albumin removal. Adv. Exp. Med Biol. 1073, 57\u201376 (2019).","journal-title":"Adv. Exp. Med Biol."},{"key":"74641_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1074-7613(03)00149-3","volume":"18","author":"SR Brodeur","year":"2003","unstructured":"Brodeur, S. R. et al. C4b-binding protein (C4BP) activates B cells through the CD40 receptor. Immunity 18, 837\u2013848 (2003).","journal-title":"Immunity"},{"key":"74641_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/TP.0000000000001341","volume":"101","author":"E Nova-Lamperti","year":"2017","unstructured":"Nova-Lamperti, E. et al. Increased CD40 ligation and reduced BCR signalling leads to higher il-10 production in B cells from tolerant kidney transplant patients. Transplantation 101, 541\u2013547 (2017).","journal-title":"Transplantation"},{"key":"74641_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35263-9","volume":"13","author":"TL Nguyen","year":"2022","unstructured":"Nguyen, T. L. et al. Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance. Nat. Commun. 13, 7449 (2022).","journal-title":"Nat. Commun."},{"key":"74641_CR39","doi-asserted-by":"publisher","first-page":"11270","DOI":"10.1073\/pnas.1120611109","volume":"109","author":"A Yeste","year":"2012","unstructured":"Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L. & Quintana, F. J. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 109, 11270\u201311275 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74641_CR40","doi-asserted-by":"publisher","first-page":"ra61","DOI":"10.1126\/scisignal.aad0612","volume":"9","author":"A Yeste","year":"2016","unstructured":"Yeste, A. et al. Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2. Sci. Signal 9, ra61 (2016).","journal-title":"Sci. Signal"},{"key":"74641_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clim.2015.03.023","volume":"160","author":"JS Lewis","year":"2015","unstructured":"Lewis, J. S. et al. A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice. Clin. Immunol. 160, 90\u2013102 (2015).","journal-title":"Clin. Immunol."},{"key":"74641_CR42","doi-asserted-by":"publisher","first-page":"24696","DOI":"10.1021\/acsnano.3c04497","volume":"17","author":"NM Phan","year":"2023","unstructured":"Phan, N. M., Nguyen, T. L., Shin, H., Trinh, T. A. & Kim, J. ROS-scavenging lignin-based tolerogenic nanoparticle vaccine for treatment of multiple sclerosis. ACS Nano 17, 24696\u201324709 (2023).","journal-title":"ACS Nano"},{"key":"74641_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biomaterials.2017.07.029","volume":"143","author":"JJ Cho","year":"2017","unstructured":"Cho, J. J. et al. An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis. Biomaterials 143, 79\u201392 (2017).","journal-title":"Biomaterials"},{"key":"74641_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","volume":"371","author":"C Krienke","year":"2021","unstructured":"Krienke, C. et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 371, 145\u2013153 (2021).","journal-title":"Science"},{"key":"74641_CR45","doi-asserted-by":"publisher","unstructured":"Runsala, M. et al. The small GTPase Rab7 regulates antigen processing in B cells in a possible interplay with autophagy machinery. Cells https:\/\/doi.org\/10.3390\/cells12212566 (2023).","DOI":"10.3390\/cells12212566"},{"key":"74641_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nri3469","volume":"13","author":"M-I Yuseff","year":"2013","unstructured":"Yuseff, M.-I., Pierobon, P., Reversat, A. & Lennon-Dum\u00e9nil, A.-M. How B cells capture, process and present antigens: a crucial role for cell polarity. Nat. Rev. Immunol. 13, 475\u2013486 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"74641_CR47","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1038\/s41590-023-01597-9","volume":"24","author":"JF Brooks","year":"2023","unstructured":"Brooks, J. F. et al. Molecular basis for potent B cell responses to antigen displayed on particles of viral size. Nat. Immunol. 24, 1762\u20131777 (2023).","journal-title":"Nat. Immunol."},{"key":"74641_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5603\/FHC.a2018.0018","volume":"56","author":"G Pyka-Fosciak","year":"2018","unstructured":"Pyka-Fosciak, G., Stasiolek, M. & Litwin, J. A. Immunohistochemical analysis of spinal cord components in mouse model of experimental autoimmune encephalomyelitis. Folia Histochem Cytobiol. 56, 151\u2013158 (2018).","journal-title":"Folia Histochem Cytobiol."},{"key":"74641_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.108221","volume":"680","author":"G Pyka-Fosciak","year":"2020","unstructured":"Pyka-Fosciak, G., Zemla, J., Lis, G. J., Litwin, J. A. & Lekka, M. Changes in spinal cord stiffness in the course of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Arch. Biochem Biophys. 680, 108221 (2020).","journal-title":"Arch. Biochem Biophys."},{"key":"74641_CR50","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.4049\/jimmunol.171.11.5876","volume":"171","author":"VS Raman","year":"2003","unstructured":"Raman, V. S., Akondy, R. S., Rath, S., Bal, V. & George, A. Ligation of CD27 on B cells in vivo during primary immunization enhances commitment to memory B cell responses1.  J. Immunol. 171, 5876\u20135881 (2003).","journal-title":"J. Immunol."},{"key":"74641_CR51","doi-asserted-by":"publisher","unstructured":"Bittner, S., Afzali, A. M., Wiendl, H. & Meuth, S. G. Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice. J Vis Exp. https:\/\/doi.org\/10.3791\/51275 (2014).","DOI":"10.3791\/51275"},{"key":"74641_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-3083.2006.01870.x","volume":"65","author":"A McNeill","year":"2007","unstructured":"McNeill, A., Spittle, E. & Backstrom, B. T. Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand. J. Immunol. 65, 63\u201369 (2007).","journal-title":"Scand. J. Immunol."},{"key":"74641_CR53","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/eji.200939613","volume":"40","author":"YY Setiady","year":"2010","unstructured":"Setiady, Y. Y., Coccia, J. A. & Park, P. U. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur. J. Immunol. 40, 780\u2013786 (2010).","journal-title":"Eur. J. Immunol."},{"key":"74641_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/eji.201646493","volume":"47","author":"F Manzoor","year":"2017","unstructured":"Manzoor, F. et al. beta-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice. Eur. J. Immunol. 47, 144\u2013154 (2017).","journal-title":"Eur. J. Immunol."},{"key":"74641_CR55","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.4049\/jimmunol.1200503","volume":"190","author":"R Olivar","year":"2013","unstructured":"Olivar, R. et al. The alpha7beta0 isoform of the complement regulator C4b-binding protein induces a semimature, anti-inflammatory state in dendritic cells. J. Immunol. 190, 2857\u20132872 (2013).","journal-title":"J. Immunol."},{"key":"74641_CR56","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.kint.2019.10.016","volume":"97","author":"A Luque","year":"2020","unstructured":"Luque, A. et al. Noncanonical immunomodulatory activity of complement regulator C4BP(beta-) limits the development of lupus nephritis. Kidney Int 97, 551\u2013566 (2020).","journal-title":"Kidney Int"},{"key":"74641_CR57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/ard.2007.085753","volume":"68","author":"AM Blom","year":"2009","unstructured":"Blom, A. M., Nandakumar, K. S. & Holmdahl, R. C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice. Ann. Rheum. Dis. 68, 136\u2013142 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"74641_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106948","volume":"197","author":"I Serrano","year":"2023","unstructured":"Serrano, I. et al. C4BP(beta-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients. Pharm. Res. 197, 106948 (2023).","journal-title":"Pharm. Res"},{"key":"74641_CR59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2221535120","volume":"120","author":"N Kapate","year":"2023","unstructured":"Kapate, N. et al. A backpack-based myeloid cell therapy for multiple sclerosis. Proc. Natl. Acad. Sci. USA 120, e2221535120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74641_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz6579","volume":"6","author":"CW Shields 4th","year":"2020","unstructured":"Shields, C. W. 4th et al. Cellular backpacks for macrophage immunotherapy. Sci. Adv. 6, eaaz6579 (2020).","journal-title":"Sci. Adv."},{"key":"74641_CR61","doi-asserted-by":"publisher","first-page":"ra175","DOI":"10.1126\/scitranslmed.3006168","volume":"5","author":"A Lutterotti","year":"2013","unstructured":"Lutterotti, A. et al. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci. Transl. Med. 5, ra175 (2013).","journal-title":"Sci. Transl. Med"},{"key":"74641_CR62","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1073\/pnas.1820039116","volume":"116","author":"I Zubizarreta","year":"2019","unstructured":"Zubizarreta, I. et al. Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial. Proc. Natl. Acad. Sci. USA 116, 8463\u20138470 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74641_CR63","doi-asserted-by":"publisher","first-page":"e030309","DOI":"10.1136\/bmjopen-2019-030309","volume":"9","author":"B Willekens","year":"2019","unstructured":"Willekens, B. et al. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. BMJ Open 9, e030309 (2019).","journal-title":"BMJ Open"},{"key":"74641_CR64","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s13311-016-0448-0","volume":"13","author":"A Belogurov Jr.","year":"2016","unstructured":"Belogurov, A. Jr. et al. CD206-targeted liposomal myelin basic protein peptides in patients with multiple sclerosis resistant to first-line disease-modifying therapies: a first-in-human, proof-of-concept dose-escalation study. Neurotherapeutics 13, 895\u2013904 (2016).","journal-title":"Neurotherapeutics"},{"key":"74641_CR65","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1021\/am3008888","volume":"4","author":"KJ Kauffman","year":"2012","unstructured":"Kauffman, K. J. et al. Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product. ACS Appl Mater. Interfaces 4, 4149\u20134155 (2012).","journal-title":"ACS Appl Mater. Interfaces"},{"key":"74641_CR66","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.4049\/jimmunol.1800031","volume":"201","author":"D Jin","year":"2018","unstructured":"Jin, D. & Sprent, J. GM-CSF culture revisited: preparation of bulk populations of highly pure dendritic cells from mouse bone marrow. J. Immunol. 201, 3129\u20133139 (2018).","journal-title":"J. Immunol."},{"key":"74641_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","volume":"223","author":"MB Lutz","year":"1999","unstructured":"Lutz, M. B. et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77\u201392 (1999).","journal-title":"J. Immunol. Methods"},{"key":"74641_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2017.11.030","volume":"270","author":"RD Junkins","year":"2018","unstructured":"Junkins, R. D. et al. A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination. J. Control Release 270, 1\u201313 (2018).","journal-title":"J. Control Release"},{"key":"74641_CR69","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jconrel.2022.05.017","volume":"347","author":"MD Gallovic","year":"2022","unstructured":"Gallovic, M. D. et al. STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant. J. Control Release 347, 356\u2013368 (2022).","journal-title":"J. Control Release"},{"key":"74641_CR70","doi-asserted-by":"publisher","first-page":"e0249117","DOI":"10.1371\/journal.pone.0249117","volume":"16","author":"EK Robinson","year":"2021","unstructured":"Robinson, E. K., Covarrubias, S., Zhou, S. & Carpenter, S. Generation and utilization of a HEK-293T murine GM-CSF expressing cell line. PLoS One 16, e0249117 (2021).","journal-title":"PLoS One"},{"key":"74641_CR71","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1534\/genetics.116.198838","volume":"206","author":"A Srivastava","year":"2017","unstructured":"Srivastava, A. et al. Genomes of the mouse collaborative cross. Genetics 206, 537\u2013556 (2017).","journal-title":"Genetics"},{"key":"74641_CR72","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1016\/j.xphs.2024.05.030","volume":"113","author":"SR Simpson","year":"2024","unstructured":"Simpson, S. R. et al. Microparticles incorporating dual apoptotic factors to inhibit inflammatory effects in macrophages. J. Pharm. Sci. 113, 3196\u20133205 (2024).","journal-title":"J. Pharm. Sci."},{"key":"74641_CR73","doi-asserted-by":"crossref","unstructured":"Benck, C. J., Martinov, T., Fife, B. T. & Chatterjea, D. Isolation of Infiltrating Leukocytes from Mouse Skin Using Enzymatic Digest and Gradient Separation. J. Vis. Exp. 107, e53638, (2016).","DOI":"10.3791\/53638-v"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74641-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:02:41Z","timestamp":1786014161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74641-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74641"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74641-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Kristy Ainslie reports National Institutes of Health provided financial support. K.M.A., E.M.B., N.R.L., D.D.M., S.A.E., M.J.I., R.T.S., K.A.C. and B.G.B. have a Provisional patent to the University of North Carolina (U.S. Provisional Patent Application No. 63\/553,404). The other authors declare no competing interests. The views reported in this paper do not reflect the views of the National Institute of Health or the United States Government.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7892"}}